Kerry Blanchard is the CEO of Everest Medicines, a Chinese biopharmaceutical company.
Kerry Blanchard is the CEO of Everest Medicines, a Chinese biopharmaceutical company. He assumed the position in February 2020. Prior to this, he served as the CSO of Innovent Biologics, and spent 17 years at Eli Lilly, where he worked on developing medicines, including abemaciclib.
Full founder directory · Investor directory · Company funding database · Fundraising library